Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).

@article{Chia2012AtropineFT,
  title={Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).},
  author={Audrey Chia and W Q Chua and Y. -B. Cheung and Wan-ling Wong and Anushia Lingham and Allan Fong and Donald Y K Tan},
  journal={Ophthalmology},
  year={2012},
  volume={119 2},
  pages={347-54}
}
PURPOSE Our previous study, Atropine for the Treatment of Myopia 1 (ATOM1), showed that atropine 1% eyedrops were effective in controlling myopic progression but with visual side effects resulting from cycloplegia and mydriasis. The aim of this study was to compare efficacy and visual side effects of 3 lower doses of atropine: 0.5%, 0.1%, and 0.01%. DESIGN Single-center, double-masked, randomized study. PARTICIPANTS A total of 400 children aged 6-12 years with myopia of at least -2.0… CONTINUE READING